Project Summary
JMM is a growing international company that offers a range of healthcare services, products, and learning programs The JMM brand is highly valued: • It’s the Australian owned healthcare company • Products are TGA approved, meeting Australia’s strict standards • It has a reputation for quality and is the only provider to enter the Chinese market • The management team has 30 years experience in the health industry • JMM uses world-class research and innovative development and delivery capabilities JMM is strongly positioned to build on its success securing a 10 year contract with Chinese Government, ‘Sales Guaranteed’ and is seeking investment to optimise the next stage for a significant return on investment • Investment: A$5 • Use: – Acquisition of original shareholder shares, sophisticated investor and equity position – Research and Development production of Healthcare, Pet and Beauty Products; and – International brand building • Current Value proposition: A$85M
Project Description
JMM seeks a A$5 million investment to fuel its growth as an international provider of healthcare services, products, and learning programs. Known for its Australian ownership and TGA-approved products, JMM has established a strong reputation for quality and is the only company entering the Chinese market with a secured 10-year government contract. With a management team boasting 30 years of experience and a focus on world-class research and innovation, JMM aims to expand further. The investment will be allocated as follows: 70% for business development, branding, and marketing in the Chinese and global markets; 15% for developing and producing JMM’s skincare and pet supplement lines under the KAYAJ brand; and 15% for acquiring original shareholder shares. The company’s current valuation is A$85 million, and this funding will optimize its next growth phase. JMM’s success in securing a contract with Sinopharm highlights its role in assisting Australian SMEs. China’s health supplements market, valued at US$45.5 billion in 2023, is growing rapidly, driven by increased health awareness post-COVID-19. JMM aims to capitalize on these trends and strengthen its global strategic position. The company seeks valuable partners and additional capital investment to support its expansion.MM International PTY Limited manufactures a variety of health products. Some of their current offerings include: Eye Vita Plus: A supplement designed to support eye health. Lung Support: A product aimed at promoting respiratory health.
Immune C 1600 Boost: A high-dose vitamin C supplement for immune support. NAD+ Super Boost: A supplement intended to enhance cellular energy and repair. Evening Primrose Oil: Known for its benefits in supporting skin and hormonal health. Liver Support: Aimed at promoting liver health and detoxification. NMN 12000: A supplement that supports anti-aging and cellular health. Wild Red Krill Oil Complex: Rich in omega-3 fatty acids, beneficial for heart and joint health. Fish Oil 1000mg: Another omega-3 supplement for overall health and Dark Propolis Capsule: Known for its antioxidant and immune-boosting properties.
Investment Opportunity Details
1. Potential to become a global market leader: Global Health and Wellness Food Markets to reach US$1.6 trillion by 2031,
2. Secured within $100 billion market space; China’s health care products market predicted to exceed 517.8 billion yuan in 2026.
3. Huge demand for anti-aging products in China and Southeast Asia , with expectation of 300 million of people >60 years old in 2025.
4. JMM is the Australian owned healthcare company and its projected that by 2030, the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30.
5. JMM is structured to meet all business requirements for the investment project.
6. Postured to proceed with further product development including WA Jarrabloom and Pet health Products
7. WA Distinct advantage -WA is uniquely Positioned to service the global rise in demand natural health supplements.
Investor information
Financial information
Investment sought: $4.6 million - $8 million
Document(s) / Video(s):
Project website:
Project information
Project highlights:
1. Potential to become a global market leader: Global Health and Wellness Food Markets to reach US$1.6 trillion by 2031,
2. Secured within $100 billion market space; China’s health care products market predicted to exceed 517.8 billion yuan in 2026.
3. Huge demand for anti-aging products in China and Southeast Asia , with expectation of 300 million of people >60 years old in 2025.
4. JMM is the Australian owned healthcare company and its projected that by 2030, the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30.
5. JMM is structured to meet all business requirements for the investment project.
6. Postured to proceed with further product development including WA Jarrabloom and Pet health Products
7. WA Distinct advantage -WA is uniquely Positioned to service the global rise in demand natural health supplements.
Project timeline:
Expected start date:
21 August, 2024
Expected end date:
31 December, 2024
Funding round finish date:
18 July, 2024
Request more information
Please fill in the form below. Mandatory fields are marked with
"*" indicates required fields
